Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00395070 · ClinicalTrials.gov registry record · Phase 3
A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma
A Phase 3 study, sponsored by Vical.
- Completed
- Registry status
- Phase 3
- Development phase
- 390
- Enrollment target
NCT00395070: Completed Phase 3 study, sponsored by Vical.
NCT00395070 is a Phase 3 study that has completed, run by Vical. The registered enrollment target is 390 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (49% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00395070, a Phase 3 study, has completed, sponsored by Vical.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 390 participants
- Enrollment target
Study Summary
To compare the safety and efficacy of Allovectin-7® versus Dacarbazine (DTIC)or Temozolomide (TMZ) in subjects with recurrent stage 3 or stage 4 melanoma.
Interventions
- DRUG Temozolomide (TMZ)
- DRUG Dacarbazine (DTIC)
- BIOLOGICAL Allovectin-7®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 390 participants |
| Start Date | 2006-10 |
| Est. Completion | 2013-07 |
| Phase | Phase 3 |
What the finished NCT00395070 record still lists
NCT00395070 is an interventional study that assigns participants to a tested intervention. The registered 390 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (49% lower).
The record links to 0 conditions, and to 3 interventions - of which Temozolomide (TMZ) is the first listed.
NCT00395070 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00395070 about?
NCT00395070 is a clinical study titled "A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma". To compare the safety and efficacy of Allovectin-7® versus Dacarbazine (DTIC)or Temozolomide (TMZ) in subjects with recurrent stage 3 or stage 4 melanoma.
What is the current status of trial NCT00395070?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 390 participants. The study started on 2006-10. Estimated completion is 2013-07.
What interventions are being tested in trial NCT00395070?
The interventions under investigation include: Temozolomide (TMZ) (DRUG), Dacarbazine (DTIC) (DRUG), Allovectin-7® (BIOLOGICAL).
Who is sponsoring clinical trial NCT00395070?
This trial is sponsored by Vical, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00395070's enrollment target sits among peer trials
390 968th of 2000 higher than 1,029 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00397111 · 390 participants
Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders
- NCT05335928 · 390 participants · Phase 3
Abatacept in Immune Checkpoint Inhibitor Myocarditis
- NCT05445960 · 390 participants · NA
Correlation Between Intraoperative Tourniquet Use and Limb pH, Functional Measures and Patient-reported Outcomes After Ankle Fracture Surgery
- NCT05997615 · 390 participants · Phase 1
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia